Patents Assigned to RI.MED FOUNDATION
  • Patent number: 12576192
    Abstract: A multi-layer device is provided that is useful in tissue regeneration, for example, for vascular regeneration, e.g., for use in treatment of a coronary vascular disease, such as for treatment of myocardial infarction. A method of making the device also is provided.
    Type: Grant
    Filed: September 11, 2023
    Date of Patent: March 17, 2026
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Ri.MED Foundation
    Inventors: Antonio D'Amore, Matteo Solazzo, William R. Wagner
  • Patent number: 12564492
    Abstract: An atrioventricular prosthesis device is provided. The device includes a frame at least partially defining and enclosing a central cavity, the frame having a distal portion, a proximal portion, and a middle portion connected therebetween. The device further includes a valve construct formed, at least in part, from a cell growth scaffold, at least partially disposed within the central cavity defined by the frame. The valve construct includes: an annular portion defining an aperture and being connected to the frame for positioning the valve construct within the central cavity of the frame, and a plurality of leaflets extending longitudinally and radially inward from the annular portion. The frame and valve construct are transitionable to a deployed state, in which a diameter of at least a portion of the frame and the valve construct substantially conform to a diameter of a tricuspid and/or mitral valve opening.
    Type: Grant
    Filed: August 9, 2023
    Date of Patent: March 3, 2026
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Ri.MED Foundation
    Inventors: Vinay Badhwar, Young Jae Chun, Antonio D'Amore, David S. Schwartzman, William R. Wagner
  • Patent number: 12508126
    Abstract: A method of making a valve structure includes a step of rotating a mandrel and an electrodeposition target attached to the mandrel about a rotational axis of the mandrel. The target includes an exterior surface having at least one conductive surface portion and at least one non-conductive surface portion. The method also includes a step of electrodepositing a polymer matrix of a biodegradable, biocompatible polymer composition onto the at least one conductive surface portion and the at least one non-conductive surface portion of the exterior surface of the rotating electrodeposition target to form the valve structure.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: December 30, 2025
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Ri.MED Foundation
    Inventors: Vinay Badhwar, Young Jae Chun, Antonio D'Amore, William R. Wagner
  • Patent number: 12280195
    Abstract: Provided herein is a percutaneous expandable venous cannula device, and related methods. The device is easily inserted, for example, using standard Seldinger technique via the right internal jugular. The device includes multiple, multi-holed limbs that softly fill, e.g., the right atrium to facilitate complete drainage, enable retraction of the chamber in surgery, and mitigate suction occlusion, filling the entire atrium and allowing for efficient and rapid emptying of the chamber. In aspects, the device facilitates minimally-invasive aortic or mitral valve surgery with single placement via the right internal jugular as the sole cannula needed for full support.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: April 22, 2025
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Ri.MED Foundation
    Inventors: Vinay Badhwar, Antonio D'Amore, Daniel McKeel, William R. Wagner
  • Patent number: 12178849
    Abstract: The present invention provides microparticles that induce the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: December 31, 2024
    Assignees: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Ri.MED Foundation
    Inventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
  • Patent number: 12077885
    Abstract: Provided herein is an electrodeposition apparatus for producing long polymeric threads, yarns, or ropes. A method of preparing long polymeric threads, yarns or ropes also is provided.
    Type: Grant
    Filed: July 15, 2020
    Date of Patent: September 3, 2024
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Ri.MED Foundation
    Inventors: Antonio D'Amore, Daniel McKeel, William R. Wagner
  • Patent number: 12070475
    Abstract: Provided herein is a ligament ECM soluble fraction useful for the growth and regrowth of ligament tissue. Methods of preparation of the soluble fractions and use of the soluble fractions in growth or regrowth of ligament tissue also are provided.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: August 27, 2024
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Ri.MED Foundation
    Inventors: Riccardo Luca Gottardi, Benjamin Burke Rothrauff, Rocky Sung Chi Tuan, Shinsuke Kihara
  • Patent number: 11318103
    Abstract: Methods for inhibiting tissue ossification or calcification in a subject, comprising administering a therapeutically effective amount of BMP I inhibitor-loaded microparticles to a subject in need thereof, wherein the administration provides local and sustained release of the BMP I inhibitor thereby inhibiting tissue ossification or calcification.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: May 3, 2022
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Ri.Med Foundation
    Inventors: Riccardo Gottardi, Peter Alexander, Patrick A. Bianconi, Steven R. Little
  • Publication number: 20210386825
    Abstract: The present invention provides microparticles that induce the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.
    Type: Application
    Filed: August 30, 2021
    Publication date: December 16, 2021
    Applicants: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Ri.MED Foundation
    Inventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
  • Patent number: 11129875
    Abstract: The present invention provides microparticles that induce the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: September 28, 2021
    Assignees: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, RI.MED FOUNDATION
    Inventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis